|Bid||128.58 x 100|
|Ask||128.61 x 3500|
|Day's Range||127.93 - 128.98|
|52 Week Range||106.87 - 131.92|
|PE Ratio (TTM)||63.31|
|Expense Ratio (net)||0.06%|
For the last several quarters, Medtronic has consistently exceeded analysts’ earnings estimates.
The proton therapy market is a highly lucrative opportunity area for Varian Medical Systems (VAR). Proton therapy uses protons for treating cancer instead of X-rays. According to a Medgadget report,…
In 2Q17, Celgene’s (CELG) Otezla generated revenues of around $358 million, which reflected ~49% growth on a year-over-year basis.